David F Ferreiro

age ~46

from Fanwood, NJ

Get Report

Also known as:

Dave Ferreiro

Phone and address:: 383 North Ave, Fanwood, NJ 07023
(917)8225219

Connected to:

David Ferreiro Phones & Addresses

383 North Ave, Fanwood, NJ 07023 • (917)8225219
72 Waldon Rd, Fanwood, NJ 07023 • (908)8891918
New York, NY
70 Greene St, Jersey City, NJ 07302 • (201)2001179
Long Island City, NY
Bronx, NY
Middlebury, VT

Work

Company:

Timessquare capital management, llc
Mar 2015
Position:

Partner

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

Albert Einstein College of Medicine
2000 to 2006
Specialities:

Immunology

Skills

Biotechnology • Medical Devices • Valuation • Financial Modeling • Venture Capital • Equity Research • Investment Banking • Due Diligence • Investments • Corporate Development • Equities • Private Equity • Economics • Capital Markets • Mergers • Portfolio Management • Healthcare • Corporate Finance • Lifesciences • Series 7 • Fixed Income • Start Ups • Hedge Funds • Bloomberg • Asset Management • Equity Valuation • Financial Analysis • Investment Management • Emerging Markets • Investor Relations • Mergers and Acquisitions • Strategy • Competitive Analysis • Alternative Investments • Business Valuation • Securities • Private Placements • M&A Experience • Life Sciences

Industries

Financial Services

Resumes

Partner

view source

Location:

New York, NY

Industry:

Financial Services

Work:

Timessquare Capital Management, Llc
Partner
Gmt Capital Feb 2014 - Feb 2015
Vice President, Investments
Oppenheimer & Co. May 2010 - Feb 2014
Executive Director, Senior Analyst
Jmp Securities Oct 2009 - May 2010
Associate
Icap Apr 2009 - Oct 2009
Strategist

Education:

Albert Einstein College of Medicine 2000 - 2006
Doctorates, Doctor of Philosophy, Immunology Middlebury College 1996 - 2000
Bachelors, Bachelor of Arts, Biology Oratory Prep 1990 - 1996

Skills:

Biotechnology
Medical Devices
Valuation
Financial Modeling
Venture Capital
Equity Research
Investment Banking
Due Diligence
Investments
Corporate Development
Equities
Private Equity
Economics
Capital Markets
Mergers
Portfolio Management
Healthcare
Corporate Finance
Lifesciences
Series 7
Fixed Income
Start Ups
Hedge Funds
Bloomberg
Asset Management
Equity Valuation
Financial Analysis
Investment Management
Emerging Markets
Investor Relations
Mergers and Acquisitions
Strategy
Competitive Analysis
Alternative Investments
Business Valuation
Securities
Private Placements
M&A Experience
Life Sciences

Wikipedia References

David Ferreiro

Flickr

News

Vertex's Kalydeco Misses Cystic-Fibrosis Study Goal

view source

Shares of Vertex rose 2.7% to $70.52 in recent Nasdaq trading. David Ferreiro, a biotechnology analyst at Oppenheimer & Co., said that though the study failed, there were some positive signs in the data that may be giving investors confidence in Kalydecos potential in other mutations.
Date: Dec 19, 2013
Category: Health
Source: Google

Rigel Sinks as Arthritis Medicine Shows Mixed Results

view source

The jury is still out on fostamatinib, David Ferreiro,an analyst with Oppenheimer & Co., wrote in a research reporttoday. He has an outperform recommendation on Rigel.Overall, we expect downside in the shares and need more datato reach a conclusion.
Date: Apr 05, 2013
Category: Business
Source: Google

Roche Says It Won't Extend Illumina Takeover Bid

view source

David Ferreiro, an analyst with Oppenheimer, said that after investors were completely focused on M&A, attention wouldreturn to business fundamentals. He predicted that when Illumina reports first-quarter results Monday, investors wouldbe interested in margins and the sustainability of consuma
Date: Apr 18, 2012
Category: Business
Source: Google